Work Wise ADHD
Adult ADHD Medication Management & Support
Work Wise ADHD is developing a private ADHD medication management pathway for UK adults with an existing diagnosis, subject to CQC registration/approval.
Planned clinical pathway
Medication review, titration, monitoring, and annual review are planned, not currently active.
CQC status
Services are planned and subject to CQC registration/approval before launch.
Planned service scope
For UK adults with an existing ADHD diagnosis
The planned pathway is for medication management only. ADHD diagnostic assessments, crisis support, therapy, counselling, coaching, and shared care guarantees are not provided.
- Review of existing ADHD diagnosis documents
- Baseline prescribing safety review
- Medication review pathway
- Planned service subject to CQC approval
Work Wise ADHD does not currently provide active private ADHD prescribing.
Planned clinical pathway
Medication management services being developed
Work Wise ADHD is the clinical education and future medication management brand. The planned service is subject to CQC registration/approval and will only open when governance, safety, and onboarding arrangements are ready.
Planned UK-only medication management
ADHD Medication Management
Private ADHD medication management services are planned for UK adults with an existing diagnosis and are subject to CQC registration/approval.
Diagnostic assessments are not provided.
- Review of existing ADHD diagnosis documents
- Baseline prescribing safety review
- Medication review pathway
- Planned service subject to CQC approval
Planned UK-only medication management pathway. Subject to CQC registration/approval. No guaranteed prescription or outcome.
Not currently offered
Clear boundaries before launch
Work Wise ADHD is not currently accepting patients for active private prescribing. The waitlist is for updates and future onboarding only.
No ADHD diagnostic assessments
No emergency or crisis support
No guaranteed prescription or shared care
What the planned service covers
Medication management, monitoring, and review preparation
The planned pathway is being designed around careful eligibility review, prescribing safety, monitoring, and realistic expectations.
Existing diagnosis review
Review of ADHD diagnostic documentation before any medication management pathway is considered.
Baseline safety checks
Physical health, cardiovascular history, medication history, and monitoring needs considered before treatment decisions.
Medication review pathway
Planned medication review, titration, monitoring, and annual review pathway, subject to CQC registration/approval.
Physical monitoring
BP, pulse, weight, side effects, response, and safety monitoring built into the planned governance pathway.
Trust
Built from clinical expertise and lived experience
Created by a UK ADHD Nurse Prescriber with clinical expertise and lived understanding of how ADHD affects real adult life.
ADHD Nurse Prescriber
Clinical prescribing expertise shaped by adult ADHD medication care.
ADHD medication experience
Experience with medication review, titration, monitoring, and treatment follow-up.
Professional and lived experience
Support designed with practical understanding of real ADHD days.
Neuro-affirming approach
Practical support that reduces shame and respects different ways of working.
Evidence-informed approach
Grounded, cautious support without overwhelming jargon.
Practical support for real life
Built around work, energy, routines, overwhelm, and follow-through.
Companion platform
Titrio Focus
Titrio Focus is the separate software/platform brand developed by Work Wise ADHD Limited.
It supports patient check-ins, monitoring prompts, review preparation, and clinic workflow support. It does not diagnose ADHD, prescribe medication, replace clinical judgement, or make automated treatment decisions.
- Titrio Focus platform
- Patient check-ins
- Review preparation
- Clinic workflow support
Choose the support that fits where you are now
Join the planned medication management waitlist, or learn about the separate Titrio Focus platform.